ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756170 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756170; 2) Community: the network communities that were significantly associated with the response to NSC 756170; 3) Molecule: the relationships between components within communities and NSC 756170; 4) MDR: the compounds that were significantly associated with the NSC 756170.

NSC Compound Enrichment Correlation
NSC 710552 Null 0.0199123109106642 0.22561071
NSC 736553 Ethyl 3-[4'-(thien-3''-yl)-1',2'-dihydronaphthalen-3'-yl]acrylate 0.0199123109106642 0.35720422
NSC 755295 2-(1-(3-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0199123109106642 0.41582984
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0209467683758286 0.45008619
NSC 267713 Digitoxigenin glycoside 0.0209467683758286 0.0068833354
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0209467683758286 0.1228993
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0209467683758286 0.45550629
NSC 34757 Melicopidine 0.0209467683758286 0.42522823
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0209467683758286 0.34827084
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0209467683758286 0.25278579
Total:100  Current:51    [First] [Prev] [Next] [Last]